AbbVie to Present at the 44th Annual J.P. Morgan Healthcare Conference
AbbVie (NYSE: ABBV) will present at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
AbbVie (NYSE: ABBV) will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026. Management will participate in a fireside chat at 10:15 a.m. Central time.
A live audio webcast will be accessible via AbbVie’s Investor Relations website at investors.abbvie.com, and an archived edition of the session will be available later the same day.
Details
News Market Reaction – ABBV
On Jan 5, the day this news came out, ABBV closed 3.98% below the previous close.
Data tracked by StockTitan Argus for the Jan 5 session.
Key Figures
- Conference edition
- 44th Annual
- J.P. Morgan Healthcare Conference
- Conference date
- January 14, 2026
- ABBV fireside chat schedule
- Presentation time
- 10:15 a.m. Central
- J.P. Morgan Healthcare Conference session
Historical Context
-
New ASH 2025 data across multiple blood cancers with strong efficacy signals.
-
Piper Sandler healthcare conference fireside chat and webcast scheduling details.
-
U.S. FDA approval of EPKINLY combo for relapsed or refractory follicular lymphoma.
-
Launch of ‘Second Winds’ film highlighting lives of people with blood cancer.
-
Announcement of 20 Migraine Career Catalyst Award recipients and support grants.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Media: Gabby Tarbert (224) 244-0111 | Investors: Liz Shea (847) 935-2211 |
View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302652210.html
SOURCE AbbVie
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.